A clinical method for testing the safety of catamenial pads.
Methods are described for assessing the gynecologic, dermatologic, and microbiologic effects of deodorant and non-deodorant catamenial pad use over a 6-month period. A controlled, randomized, investigator-blind parallel study was conducted with 190 women between the ages of 18 and 45 years. Data on medical histories, physical examinations, diagnostic laboratory tests, gynecologic and dermatologic examinations and microbiology were collected. No significant differences in gynecologic, dermatologic, or microbiologic parameters were observed between control and treated groups, and no pad-related adverse health effects were observed in this clinical study.
Farage-Elawar
M A
MA
Procter and Gamble Company, Paper Products Division, Cincinnati, Ohio 45224, USA.
Enane
N A
NA
Baldwin
S
S
Sarbaugh
F C
FC
Bergholz
C
C
Berg
R W
RW
D000293:Adolescent; D000328:Adult; D017449:Dermatitis, Allergic Contact / Q000209:etiology; D003944:Diagnostic Techniques, Obstetrical and Gynecological; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006119:Groin; D006801:Humans; D006920:Hygiene; D008598:Menstruation; D008875:Middle Aged; D010808:Physical Examination; D012449:Safety; D013630:Tampons, Surgical / Q000009:adverse effects*; D014621:Vagina / Q000382:microbiology; D014623:Vaginal Diseases / Q000382:microbiology